Followers

NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination

NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination
Spravato (pictured), a nasal spray also known as esketamine, got the green light from the European Medicines Agency in December 2019 as a fast-acting treatment for depression sufferers.

* This article was originally published here

Comments

Popular posts from this blog

Politicians are wrong about what the public want

Furious Brussels tells EU states to ignore UK as huge trade deal erupts

Federal Suit Hits Soros for $10 Billion for ‘Political Meddling, Motivated Solely by Malice’